Skip to main content
Clinical Trials/DRKS00005608
DRKS00005608Completed未知

Topical methylprednisolone aceponate in an induced eczema model - TOM-IE

Charité Campus Charité Mitte0 sites31 target enrollmentStarted: January 26, 2021Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
31

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomized controlled study
Masking
Blinded (masking used)

Eligibility Criteria

Ages
18 Years to 60 Years (—)
Sex
All

Inclusion Criteria

  • Healthy, caucasian, male and female adult volunteers, aged between 18 and 60 years (in total 30) will be recruited for this study.
  • Written informed consent
  • Fitzpatrick skin type II – III;
  • patients demonstrating irritative skin reaction to 24 h occluded epicutaneous test with 1 % SLS, i.e. ‘responders’;

Exclusion Criteria

  • skin disease

Investigators

Sponsor
Charité Campus Charité Mitte

Similar Trials